Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
HIV PrEP Is Approved in Scotland
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Thursday, 13 April 2017 00:00
- Written by Gus Cairns
The Scottish Medicines Consortium (SMC) announced this week that it had accepted tenofovir disoproxil fumarate/emtricitabine (Truvada) for use within the Scottish National Health Service as pre-exposure prophylaxis (PrEP) to prevent HIV infection.
BHIVA 2017: Large Fall in London HIV Diagnoses Is Due to Combination Prevention, Not Just PrEP
- Details
- Category: Treatment as Prevention
- Published on Thursday, 13 April 2017 00:00
- Written by Roger Pebody
The number of new HIV diagnoses among gay men attending 5 key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England reported at the British HIV Association (BHIVA) conference last week in Liverpool.
CROI 2017: STI Rates Among PrEP Users Are High, But Evidence that PrEP Increases Them Is Inconclusive
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 27 February 2017 00:00
- Written by Gus Cairns
A study of pre-exposure prophylaxis (PrEP) users presented at the Conference on Retroviruses and Opportunistic Infections this month in Seattle showed that they had very high rates of sexually transmitted infection (STI) diagnosis -- on the order of 20 times higher than among HIV-negative gay men in the general population. However, it is unclear whether STIs increased further after people went on PrEP.
CROI 2017: Bacterial Vaginosis Does Not Affect Efficacy of Oral PrEP in Women
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 08 March 2017 00:00
- Written by Gus Cairns
Research presented at the Conference on Retroviruses and Opportunistic Infections last month in Seattle found that the efficacy of oral pre-exposure prophylaxis (PrEP) for women was not affected by bacterial vaginosis (BV) -- the overgrowth in the vagina of untypical microbes. The effectiveness of PrEP in the Partners PrEP study was not significantly different in women with and without BV. This rules out BV as a possible cause for the lower effectiveness of oral PrEP in some studies of women compared to studies of men who have sex with men.
CROI 2017: Unique Case of PrEP Failure Without Drug Resistance Reported in Amsterdam
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 20 February 2017 00:00
- Written by Gus Cairns
HIV pre-exposure prophylaxis (PrEP) appears to be nearly 100% effective if taken consistently. However, among tens of thousands of cases of PrEP preventing HIV, there have been a few reports of people who acquired HIV despite high adherence to PrEP and adequate drug levels, including one reported in a poster at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) last week in Seattle.
More Articles...
- CROI 2017: STI Prophylaxis in PrEP Users Reduces Syphilis and Chlamydia, but Not Gonorrhea
- Hope Overshadowed -- The National HIV PrEP Summit
- No New HIV Infections in Northern California Kaiser PrEP Program, but STI Rates Rising
- U.K.'s Largest Sexual Health Clinic Saw 40% Drop in New HIV Diagnoses in 2016
Web Design and Development by